Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Sep;19(9):1561-1569.
doi: 10.1513/AnnalsATS.202111-1253OC.

Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study

Affiliations
Multicenter Study

Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study

Roger Y Kim et al. Ann Am Thorac Soc. 2022 Sep.

Abstract

Rationale: Black patients receive recommended lung cancer screening (LCS) follow-up care less frequently than White patients, but it is unknown if this racial disparity persists across both decentralized and centralized LCS programs. Objectives: To determine adherence to American College of Radiology Lung Imaging Reporting and Data System (Lung-RADS) recommendations among individuals undergoing LCS at either decentralized or centralized programs and to evaluate the association of race with LCS adherence. Methods: We performed a multicenter retrospective cohort study of patients receiving LCS at five heterogeneous U.S. healthcare systems. We calculated adherence to annual LCS among patients with a negative baseline screen (Lung-RADS 1 or 2) and recommended follow-up care among those with a positive baseline screen (Lung-RADS 3, 4A, 4B, or 4X) stratified by type of LCS program and evaluated the association between race and adherence using multivariable modified Poisson regression. Results: Of the 6,134 total individuals receiving LCS, 5,142 (83.8%) had negative baseline screens, and 992 (16.2%) had positive baseline screens. Adherence to both annual LCS (34.8% vs. 76.1%; P < 0.001) and recommended follow-up care (63.9% vs. 74.6%; P < 0.001) was lower at decentralized compared with centralized programs. Among individuals with negative baseline screens, a racial disparity in adherence was observed only at decentralized screening programs (interaction term, P < 0.001). At decentralized programs, Black race was associated with 27% reduced adherence to annual LCS (adjusted relative risk [aRR], 0.73; 95% confidence interval [CI], 0.63-0.84), whereas at centralized programs, no effect by race was observed (aRR, 0.98; 95% CI, 0.91-1.05). In contrast, among those with positive baseline screens, there was no significant difference by race for adherence to recommended follow-up care by type of LCS program (decentralized aRR, 0.95; 95% CI, 0.81-1.11; centralized aRR, 0.81; 95% CI, 0.71-0.93; interaction term, P = 0.176). Conclusions: In this large multicenter study of individuals screened for lung cancer, adherence to both annual LCS and recommended follow-up care was greater at centralized screening programs. Black patients were less likely to receive annual LCS than White patients at decentralized compared with centralized LCS programs. Our results highlight the need for further study of healthcare system-level mechanisms to optimize longitudinal LCS care.

Keywords: early detection of cancer; guideline adherence; healthcare disparities.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Assembly of the analytic sample. LCS = lung cancer screening; Lung-RADS = Lung Imaging Reporting and Data System.
Figure 2.
Figure 2.
Association of race with adherence to annual lung cancer screening (Lung Imaging Reporting and Data System [Lung-RADS] 1 or 2) and recommended follow-up care (Lung-RADS 3 or 4) stratified by type of screening program. Dots illustrate adjusted relative risk (aRR) effect estimates for Black versus White race and horizontal lines, 95% confidence intervals (CIs). The vertical dashed line represents the null hypothesis of aRR = 1.0. Models included an interaction term for race and type of lung cancer screening program and were adjusted for baseline screen Lung-RADS score, age, sex, smoking status, Charlson comorbidity index, body mass index, year of baseline screen, median family income, and highest level of education. Study site heterogeneity was modeled as random effects.

Comment in

References

    1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med . 2011;365:395–409. - PMC - PubMed
    1. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med . 2020;382:503–513. - PubMed
    1. Moyer VA, U.S. Preventive Services Task Force Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med . 2014;160:330–338. - PubMed
    1. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol . 2017;3:1278–1281. - PMC - PubMed
    1. American College of Radiology Committee on Lung-RADS 2021https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADSAssessmentC....

Publication types